| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad87571223355d0e8593c06ab59a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42cf1f1a259837dd8732a465b57ec5db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc9c1c7e8310001f6eb9086b33df221 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2010-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b5d210a0fbd9a864853998d5e16197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8685aaadffe96a880dd1d131c0caf56f |
| publicationDate |
2011-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011067175-A1 |
| titleOfInvention |
Ofa/ilrp derived modified peptide |
| abstract |
The present invention relates to a novel modified human oncofoetal antigen immature laminin receptor (OFA/iLR)- derived peptide comprising the sequence VLIENPADV, its stereoisomers, its peptide analogues and mixtures thereof and theiruse for diagnostic and therapeutic purposes, specifically in cancer. |
| priorityDate |
2009-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |